Our take on Avidity's FORTITUDE phase 1/2 trial data
from MyFSHD Hosted by Peter L Jones, PhD
"I'll have what she's having." We'll take you through and discuss the recent release of Avidity Biosciences topline results from the phase 1/2 FORTITUDE trial and the preliminary data from the biomarker cohort extension.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of MyFSHD?
This episode is 54 minutes long.
When was this MyFSHD episode published?
This episode was published on June 11, 2025.
Can I download this MyFSHD episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.